Evidence map›Paper›PMID 38931972›Full record

ReviewPolymers2024

Carbon Recycling of High Value Bioplastics: A Route to a Zero-Waste Future.

Matthew Keith, Martin Koller, Maximilian Lackner

Abstract readReview
In one paragraph

Review in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Matthew KeithSchool of Chemical Engineering, University of Birmingham, Birmingham B15 2TT, UK.ORCID 0000-0001-5328-5271
Martin KollerInstitute of Chemistry, NAWI Graz, University of Graz, 8010 Graz, Austria.ORCID 0000-0002-9251-1822
Maximilian LacknerGo!PHA, Oudebrugsteeg 9, 1012 JN Amsterdam, The Netherlands.ORCID 0000-0002-2673-7495

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Today, 98% of all plastics are fossil-based and non-biodegradable, and globally, only 9% are recycled. Microplastic and nanoplastic pollution is just beginning to be understood. As the global demand for sustainable alternatives to conventional plastics continues to rise, biobased and biodegradable plastics have emerged as a promising solution. This review article delves into the pivotal concept of carbon recycling as a pathway towards achieving a zero-waste future through the production and utilization of high-value bioplastics. The review comprehensively explores the current state of bioplastics (biobased and/or biodegradable materials), emphasizing the importance of carbon-neutral and circular approaches in their lifecycle. Today, bioplastics are chiefly used in low-value applications, such as packaging and single-use items. This article sheds light on value-added applications, like longer-lasting components and products, and demanding properties, for which bioplastics are increasingly being deployed. Based on the waste hierarchy paradigm-reduce, reuse, recycle-different use cases and end-of-life scenarios for materials will be described, including technological options for recycling, from mechanical to chemical methods. A special emphasis on common bioplastics-TPS, PLA, PHAs-as well as a discussion of composites, is provided. While it is acknowledged that the current plastics (waste) crisis stems largely from mismanagement, it needs to be stated that a radical solution must come from the core material side, including the intrinsic properties of the polymers and their formulations. The manner in which the cascaded use of bioplastics, labeling, legislation, recycling technologies, and consumer awareness can contribute to a zero-waste future for plastics is the core topics of this article.

Indexed as

alternativesbiodegradationbiopolymerscircular economyexternalized costsPHA (polyhydroxyalkanoates)plasticsrecyclingsubstituteswaste management

Identifiers

PMID38931972
PMCPMC11207349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.